40 related articles for article (PubMed ID: 23324159)
1. No evidence for carcinogenicity of titanium dioxide nanoparticles in 26-week inhalation study in rasH2 mouse model.
Yamano S; Takeda T; Goto Y; Hirai S; Furukawa Y; Kikuchi Y; Kasai T; Misumi K; Suzuki M; Takanobu K; Senoh H; Saito M; Kondo H; Umeda Y
Sci Rep; 2022 Sep; 12(1):14969. PubMed ID: 36056156
[TBL] [Abstract][Full Text] [Related]
2. Sodium Valproate Enhances the Urethane-Induced Lung Adenomas and Suppresses Malignization of Adenomas in Ovariectomized Female Mice.
Stakisaitis D; Mozuraite R; Juodziukyniene N; Didziapetriene J; Uleckiene S; Matusevicius P; Valanciute A
Int J Endocrinol; 2015; 2015():218219. PubMed ID: 26491438
[TBL] [Abstract][Full Text] [Related]
3. Regulatory Forum Opinion Piece*: Retrospective Evaluation of Doses in the 26-week Tg.rasH2 Mice Carcinogenicity Studies: Recommendation to Eliminate High Doses at Maximum Tolerated Dose (MTD) in Future Studies.
Paranjpe MG; Denton MD; Vidmar TJ; Elbekai RH
Toxicol Pathol; 2015 Jul; 43(5):611-20. PubMed ID: 25391312
[TBL] [Abstract][Full Text] [Related]
4. Trend analysis of body weight parameters, mortality, and incidence of spontaneous tumors in Tg.rasH2 mice.
Paranjpe MG; Denton MD; Vidmar T; Elbekai RH
Int J Toxicol; 2014; 33(6):475-81. PubMed ID: 25260361
[TBL] [Abstract][Full Text] [Related]
5. The 26-week Tg.rasH2 mice carcinogenicity studies: microscopic examination of only select tissues in low- and mid-dose groups.
Paranjpe MG; Denton MD; Elbekai RH
Toxicol Pathol; 2014 Oct; 42(7):1153-7. PubMed ID: 23960167
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Spontaneous Tumors in Tg.rasH2 Mice in 26-week Carcinogenicity Studies Conducted at a Single Test Facility during 2004 to 2012 and 2013 to 2018.
Paranjpe MG; Belich JL; Mann PC; McKeon ME; Elbekai RH; Brown CM; Patrick DJ
Toxicol Pathol; 2019 Jan; 47(1):18-25. PubMed ID: 30407148
[TBL] [Abstract][Full Text] [Related]
7. Organ accumulation and carcinogenicity of highly dispersed multi-walled carbon nanotubes administered intravenously in transgenic rasH2 mice.
Sobajima A; Haniu H; Nomura H; Tanaka M; Takizawa T; Kamanaka T; Aoki K; Okamoto M; Yoshida K; Sasaki J; Ajima K; Kuroda C; Ishida H; Okano S; Ueda K; Kato H; Saito N
Int J Nanomedicine; 2019; 14():6465-6480. PubMed ID: 31616140
[TBL] [Abstract][Full Text] [Related]
8. Carcinogenicity of intermediate frequency magnetic field in Tg.rasH2 mice.
Nishimura I; Doi Y; Imai N; Kawabe M; Mera Y; Shiina T
Bioelectromagnetics; 2019 Apr; 40(3):160-169. PubMed ID: 30875092
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical characterization of urethane-induced lung tumors in CB6F1-Tg rasH2 mice.
Sano T; Watanabe T; Ishimura Y; Anayama H
J Toxicol Pathol; 2017 Apr; 30(2):177-181. PubMed ID: 28458456
[TBL] [Abstract][Full Text] [Related]
10. Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse.
Berridge BR; Mowat V; Nagai H; Nyska A; Okazaki Y; Clements PJ; Rinke M; Snyder PW; Boyle MC; Wells MY
J Toxicol Pathol; 2016; 29(3 Suppl):1S-47S. PubMed ID: 27621537
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors.
Mitsumori K; Wakana S; Yamamoto S; Kodama Y; Yasuhara K; Nomura T; Hayashi Y; Maronpot RR
Mol Carcinog; 1997 Nov; 20(3):298-307. PubMed ID: 9397190
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous tumor incidence in rasH2 mice: review of internal data and published literature.
Nambiar PR; Turnquist SE; Morton D
Toxicol Pathol; 2012 Jun; 40(4):614-23. PubMed ID: 22328410
[TBL] [Abstract][Full Text] [Related]
13. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies.
Mitsumori K; Koizumi H; Nomura T; Yamamoto S
Toxicol Pathol; 1998; 26(4):520-31. PubMed ID: 9715511
[TBL] [Abstract][Full Text] [Related]
14. The Tg rasH2 mouse in cancer hazard identification.
Morton D; Alden CL; Roth AJ; Usui T
Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
[TBL] [Abstract][Full Text] [Related]
15. Historical control data of spontaneous tumors in transgenic CByB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice.
Paranjpe MG; Elbekaei RH; Shah SA; Hickman M; Wenk ML; Zahalka EA
Int J Toxicol; 2013; 32(1):48-57. PubMed ID: 23324159
[TBL] [Abstract][Full Text] [Related]
16. Incidence of spontaneous non-neoplastic lesions in transgenic CBYB6F1-Tg(HRAS)2Jic mice.
Paranjpe MG; Shah SA; Denton MD; Elbekai RH
Toxicol Pathol; 2013; 41(8):1137-45. PubMed ID: 23427275
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
